Chronic renal disease is more prevalent in patients with hemolytic uremic syndrome who had a positive history of diarrhea

Kidney International

Volumn 78, Issue 6, 2010, Pages 598-604

  Sharma, Ajay P ^a   Filler, Guido ^a   Dwight, Prabo ^a   Clark, William F ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

albuminuria; diarrhea positive; E. coli O157:H7; GFR; HUS; renal sequelae

Indexed keywords

CYSTATIN C;

ADOLESCENT; AGE; ALBUMINURIA; ARTICLE; BLOODY DIARRHEA; CHILD; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIARRHEA; ESCHERICHIA COLI O157; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 77956228365     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.174     Document Type: Article

References (52)

1. Martin DL, MacDonald KL, White KE et al. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med 1990; 323: 1161-1167.
2. Siegler R, Oakes R. Hemolytic uremic syndrome; pathogenesis, treatment, and outcome. Curr Opin Pediatr 2005; 17: 200-204.
3. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 1996; 49: 1774-1777.
4. Small G, Watson AR, Evans JH et al. Hemolytic uremic syndrome: defining the need for long-term follow-up. Clin Nephrol 1999; 52: 352-356.
5. McLean MM, Jones CH, Sutherland DA. Haemolytic-uraemic syndrome. A report of an outbreak. Arch Dis Child 1966; 41: 76-81.
6. Vermylen C, Bodart E, Ninane J et al. The haemolytic uraemic syndrome of childhood: is living in Belgium a factor of good prognosis? Acta Clin Belg 1988; 43: 101-108.
7. Cordero J, Baeza J, Fielbaum O et al. [Hemolytic-uremic syndrome. Experience with 154 cases]. Rev Chil Pediatr 1990; 61: 235-242.
8. Schieppati A, Ruggenenti P, Cornejo RP et al. Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. The Italian Registry of haemolytic uremic syndrome. J Am Soc Nephrol 1992; 2: 1640-1644.
9. Cobenas CJ, Alconcher LF, Spizzirri AP et al. Long-term follow-up of Argentinean patients with hemolytic uremic syndrome who had not undergone dialysis. Pediatr Nephrol 2007; 22: 1343-1347.
10. Spizzirri FD, Rahman RC, Bibiloni N et al. Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 1997; 11: 156-160.
11. O'Regan S, Blais N, Russo P et al. Hemolytic uremic syndrome: glomerular filtration rate, 6 to 11 years later measured by 99mTc DTPA plasma slope clearance. Clin Nephrol 1989; 32: 217-220.
12. Huseman D, Gellermann J, Vollmer I et al. Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow. Pediatr Nephrol 1999; 13: 672-677.
13. Campos A, Kim Y, Miller K et al. Radionuclide studies of the kidney in children with hemolytic-uremic syndrome. Radiology 1982; 145: 811-813.
14. Gianantonio CA, Vitacco M, Mendilaharzu F et al. The hemolytic-uremic syndrome. Renal status of 76 patients at long-term follow-up. J Pediatr 1968; 72: 757-765.
15. Tonshoff B, Sammet A, Sanden I et al. Outcome and prognostic determinants in the hemolytic uremic syndrome of children. Nephron 1994; 68: 63-70.
16. Blahova K, Janda J, Kreisinger J et al. Long-term follow-up of Czech children with D+ hemolytic-uremic syndrome. Pediatr Nephrol 2002; 17: 400-403.
17. Sorrenti LY, Lewy PR. The hemolytic-uremic syndrome: experience at a center in the Midwest. Am J Dis Child 1978; 132: 59-62.
18. Kelles A, Van Dyck M, Proesmans W. Childhood haemolytic uraemic syndrome: long-term outcome and prognostic features. Eur J Pediatr 1994; 153: 38-42.
19. Hughes DA, Beattie TJ, Murphy AV. Haemolytic uraemic syndrome: 17 years' experience in a Scottish paediatric renal unit. Scott Med J 1991; 36: 9-12.
20. De Jong M, Monnens L. Haemolytic-uraemic syndrome: a 10-year follow-up study of 73 patients. Nephrol Dial Transplant 1988; 3: 379-382.
21. Garg AX, Suri RS, Barrowman N et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 2003; 290: 1360-1370.
22. Jones CA, Francis ME, Eberhardt MS et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39: 445-459.
23. Burgert TS, Dziura J, Yeckel C et al. Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors. Int J Obes (Lond) 2006; 30: 273-280.
24. Salvadori M, Sontrop JM, Garg AX et al. Elevated blood pressure in relation to overweight and obesity among children in a rural Canadian community. Pediatrics 2008; 122: e821-e827.
25. Garg AX, Salvadori M, Okell JM et al. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update. Am J Kidney Dis 2008; 51: 435-444.
26. Hughes AK, Ergonul Z, Stricklett PK et al. Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression. J Am Soc Nephrol 2002; 13: 2239-2245.
27. Hughes AK, Stricklett PK, Kohan DE. Cytotoxic effect of shiga toxin-1 on human proximal tubule cells. Kidney Int 1998; 54: 426-437.
28. Van Setten PA, van Hinsbergh VW, Van den Heuvel LP et al. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. J Am Soc Nephrol 1997; 8: 1877-1888.
29. Lopez EL, Contrini MM, Devoto S et al. Incomplete hemolytic-uremic syndrome in Argentinean children with bloody diarrhea. J Pediatr 1995; 127: 364-367.
30. Koster F, Levin J, Walker L et al. Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med 1978; 298: 927-933.
31. Ake JA, Jelacic S, Ciol MA et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 2005; 115: e673-e680.
32. Kristman V, Manno M, Cote P. Loss to follow-up in cohort studies: how much is too much? Eur J Epidemiol 2004; 19: 751-760.
33. Acock A. Working with missing data. Family Science Review 1997; 1: 76-102.
34. Raghunathan TE. What do we do with missing data? Some options for analysis of incomplete data. Annu Rev Public Health 2004; 25: 99-117.
35. Ogborn MR, Hamiwka L, Orrbine E et al. Renal function in Inuit survivors of epidemic hemolytic-uremic syndrome. Pediatr Nephrol 1998; 12: 485-1458
36. Manning SD, Motiwala AS, Springman AC et al. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci USA 2008; 105: 4868-4873.
37. Repetto HA. Long-term course and mechanisms of progression of renal disease in hemolytic uremic syndrome. Kidney Int Suppl 2005; 97: S102-S106.
38. Garg AX, Moist L, Matsell D et al. Risk of hypertension and reduced kidney function after acute gastroenteritis from bacteria-contaminated drinking water. CMAJ 2005; 173: 261-268.
39. Filler G, Lepage N. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 2003; 18: 981-985.
40. Bokenkamp A, Domanetzki M, Zinck R et al. Cystatin C-a new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998; 101: 875-881.
41. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-226.
42. Huppertz HI, Busch D, Schmidt H et al. Diarrhea in young children associated with Escherichia coli non-O157 organisms that produce shiga-like toxin. J Pediatr 1996; 128: 341-346.
43. http://www.cdc.gov/nchs/about/major/nhanes/growthcharts/zscores/zscores. htm. last accessed, 6 September 2009.
44. Barratt TM, McLaine PN, Soothill JF. Albumin excretion as a measure of glomerular dysfunction in children. Arch Dis Child 1970; 45: 496-501.
45. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1): S1-S266.
46. Mueller PW, Caudill SP. Urinary albumin excretion in children: factors related to elevated excretion in the United States population. Ren Fail 1999; 21: 293-302.
47. Schwartz GJ, Haycock GB, Edelmann Jr CM et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263.
48. Filler G, Foster J, Acker A et al. The Cockcroft-Gault formula should not be used in children. Kidney Int 2005; 67: 2321-2324.
49. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
50. Sharma AP, Kathiravelu A, Nadarajah R et al. Body mass does not have a clinically relevant effect on cystatin C eGFR in children. Nephrol Dial Transplant 2009; 24: 470-474.
51. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114(2 Suppl 4th Report): 555-576.
52. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.